Last updated: 2026-10-13 11:43:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
West Pharmaceutical Services, Inc. (WST) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $370.34, with a market capitalisation of $25.76B and a P/E ratio of 45.80. Over the past 52 weeks, its price has ranged from $223.83 to $386.00. This page covers its latest market performance, valuation, price trends and company information.
$25.76B | |
$370.34 | |
$475.35 | |
$7.68 | |
$367.60 | |
101.00 | |
620.70K | |
45.80 | |
$386.00 | |
$223.83 | |
0.23% | |
-- |
West Pharmaceutical Services, Inc. (WST) is trading at $370.34 in pre-market trading as of 2026-10-13 11:39:00, up 0.75% ($2.74) from the previous close of $367.60
Pre-market trading shows how investors are pricing WST before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, West Pharmaceutical Services, Inc. (WST) moved from $364.98 to $370.34, representing a gain of 1.47% ($5.36).
The stock traded between $359.49 and $381.16 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 470.64 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 90.3%
WST is currently trading at $370.34, placing it 90.3% of the way from its 52-week low of $223.83 to its 52-week high of $386.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 10800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of West Pharmaceutical Services, Inc. (WST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.